When Side Effects Push Users Away Additionally, people who had previously used gastrointestinal medicationswhich may indicate they are more vulnerable to the common adverse gastrointestinal side-effects reported by GLP1-RA users, such as nausea, vomiting, diarrheawere 9% more likely to discontinue semaglutide within the first year
The study was published on March 30 in the Journal of the American College of Cardiology: Clinical Electrophysiology
Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers
Intravenous or IV therapy is becoming increasingly popular as a trusted medical treatment for delivering fluids, medications, and nutrients directly into the bloodstream
It supports metabolism, blood sugar balance, appetite control, and healthy fat loss , promoting overall vitality.
adults now classified as obese and more than 70% overweight